Open AccessObesity and nonalcoholic fatty liver disease: metabolic risks and their correction
Author(s) -
K. A. Komshilova,
Комшилова Ксения Андреевна,
Е. А. Трошина,
Трошина Екатерина Анатольевна
Publication year - 2015
Publication title -
ožirenie i metabolizm
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.154
H-Index - 5
eISSN - 2306-5524
pISSN - 2071-8713
DOI - 10.14341/omet2015234-38
Subject(s) - nonalcoholic fatty liver disease , metabolic syndrome , fatty liver , medicine , obesity , disease , diabetes mellitus , type 2 diabetes , abdominal obesity , gastroenterology , pathogenesis , insulin resistance , chronic liver disease , incidence (geometry) , bioinformatics , endocrinology , biology , cirrhosis , physics , optics
Nonalcoholic fatty liver disease (NAFLD) – a common chronic disease of the liver, the main feature of which is the accumulation of fat in hepatocytes, is not related to alcohol abuse. NAFLD is associated with obesity, especially abdominal, metabolic syndrome and various metabolic markers of risk for cardiovascular disease and type 2 diabetes, which affects the incidence, prognosis and life expectancy of patients with obesity. This lecture describes the main causes of the disease, its pathogenesis, clinical presentation, diagnosis and treatment.